Pharmstandard Investor

Pharmstandard develops and manufactures pharmaceutical products designed to meet the requirements of the healthcare system and the needs of patients. Pharmstandard manufactures medicines for a range of conditions, including cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological disorders, metabolic disorders, oncology, and other illnesses.

Headquarters: Moscow,Moscow City,Russian Federation,Europe
Employee Number: 5001-10000
Industry: Advanced BioTech R&D
Number Of Exists: 6
Investor Type: Private Equity Funds
Founded Date: 2003-01-01
Funding Status: delisted